Occupe actuellement des postes chez BridgeBio Pharma Inc, Genentech Inc and Alector Inc
Position | Company | Period |
---|---|---|
Chairman of Research and Development, Director | BridgeBio Pharma Inc | 1 janvier 2019 - |
Executive Vice President - Research, Chief Scientific Officer | Genentech Inc | 1 janvier 2008 - |
Independent Director | Alector Inc | 1 octobre 2018 - |
Independent Director | Xenon Pharmaceuticals Inc | 16 mars 2015 - 14 janvier 2020 |
Director | BridgeBio Pharma Inc | 1 janvier 2018 - 1 janvier 2019 |
Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development | Roche Holding AG | 1 janvier 2009 - 31 décembre 2014 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2022-11-14 | 2022-11-11 |
VG Acquisition Corp
(VGAC)
|
V Vente |
18 421
-20.3%
3,2459 684 USD |
18 421 -20.3% | 3,24 | 59 684 USD | |
2021-05-24 | 2021-05-24 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
100
-0.3%
25,002 500 USD |
100 -0.3% | 25,00 | 2 500 USD | |
2021-05-24 | 2021-05-21 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
1 231
-3.0%
25,1931 008 USD |
1 231 -3.0% | 25,19 | 31 008 USD | |
2021-05-24 | 2021-05-20 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
659
-1.6%
25,0816 528 USD |
659 -1.6% | 25,08 | 16 528 USD | |
2021-05-18 | 2021-05-18 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
2 800
-6.4%
25,3470 958 USD |
2 800 -6.4% | 25,34 | 70 958 USD | |
2021-05-18 | 2021-05-17 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
500
-1.1%
25,0612 530 USD |
500 -1.1% | 25,06 | 12 530 USD | |
2021-05-18 | 2021-05-14 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
4 615
-9.4%
25,38117 117 USD |
4 615 -9.4% | 25,38 | 117 117 USD | |
2021-04-05 | 2021-04-01 |
Oric Pharmaceuticals Inc
(ORIC)
|
VP Vente planifiée |
200
-0.4%
25,005 000 USD |
200 -0.4% | 25,00 | 5 000 USD | |
2020-12-23 | 2020-12-21 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
45 473
-49.8%
65,482 977 699 USD |
45 473 -49.8% | 65,48 | 2 977 699 USD | |
2020-12-23 | 2020-12-21 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
14 928
-14.0%
64,81967 437 USD |
14 928 -14.0% | 64,81 | 967 437 USD | |
2020-12-21 | 2020-12-18 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
2 895
-2.7%
65,78190 432 USD |
2 895 -2.7% | 65,78 | 190 432 USD | |
2020-12-21 | 2020-12-18 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
27 105
-19.9%
64,991 761 589 USD |
27 105 -19.9% | 64,99 | 1 761 589 USD | |
2020-12-17 | 2020-12-15 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
19 352
-12.4%
60,731 175 303 USD |
19 352 -12.4% | 60,73 | 1 175 303 USD | |
2020-12-17 | 2020-12-15 |
BridgeBio Pharma Inc
(BBIO)
|
V Vente |
12 091
-7.2%
59,81723 114 USD |
12 091 -7.2% | 59,81 | 723 114 USD | |
2020-09-18 | 2020-09-16 |
BridgeBio Pharma Inc
(BBIO)
|
VP Vente planifiée |
25 000
-15.3%
37,50937 500 USD |
25 000 -15.3% | 37,50 | 937 500 USD | |
2020-02-06 | 2020-02-04 |
Alector Inc
(ALEC)
|
VP Vente planifiée |
10 000
-50.0%
29,67296 700 USD |
10 000 -50.0% | 29,67 | 296 700 USD | |
2004-05-17 | 2004-05-13 |
Genentech Inc
(DNA)
|
V Vente |
100
-100.0%
61,616 161 USD |
100 -100.0% | 61,61 | 6 161 USD | |
2004-05-17 | 2004-05-13 |
Genentech Inc
(DNA)
|
V Vente |
500
-100.0%
61,6030 800 USD |
500 -100.0% | 61,60 | 30 800 USD | |
2004-05-17 | 2004-05-13 |
Genentech Inc
(DNA)
|
V Vente |
800
-100.0%
61,5949 272 USD |
800 -100.0% | 61,59 | 49 272 USD | |
2004-05-17 | 2004-05-13 |
Genentech Inc
(DNA)
|
V Vente |
5 893
-100.0%
61,58362 891 USD |
5 893 -100.0% | 61,58 | 362 891 USD | |
2004-05-07 | 2004-05-06 |
Genentech Inc
(DNA)
|
V Vente |
1 354
-100.0%
124,00167 896 USD |
1 354 -100.0% | 124,00 | 167 896 USD | |
2004-05-07 | 2004-05-06 |
Genentech Inc
(DNA)
|
V Vente |
2 604
-100.0%
124,00322 896 USD |
2 604 -100.0% | 124,00 | 322 896 USD |